Sign inJoin waitlistJoin the waitlist

Harmeet Malhi

NIH-Sponsored Track Director · Mayo Clinic College of Medicine and Science

Credentials: · · · ·

History

Division of Gastroenterology and Hepatology · Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Gastroenterology
Mayo Clinic College of Medicine and Science
2001–2004
2000–2001
Research Associate Albert Einstein College of Medicine
Internal Medicine
Mayo Clinic College of Medicine and Science
1997–2000
UNIV COLL OF MED SCIENCES, NEW DELHI, DELHI
1993–1997

Research

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014…
Journal of Extracellular Vesicles · 2018 · 9,216 citations
Endoplasmic reticulum stress in liver disease
Review · Journal of Hepatology · 2011 · First of 2 authors · 997 citations
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis
Journal of Biological Chemistry · 2006 · First of 4 authors · 607 citations

Gregory Gores
39 papers
Vijay Shah
22 papers
TS
Tejasav Sehrawat
12 papers · 12 as a resident
Gopanandan Parthasarathy
9 papers · 7 as a fellow
Samar Ibrahim
8 papers
Alina Allen
6 papers · 1 as a fellow
BJ
Brigid Joseph
6 papers
Patrick Kamath
6 papers
AI
Adil Irani
5 papers · 2 as a fellow
Doug Simonetto
5 papers · 3 as a fellow
Elliot Tapper
5 papers
GM
George Marek
5 papers · 5 as a fellow

Grants

Multidisciplinary Training in Digestive Diseases
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $1.4M · Mayo Clinic Rochester
1979–2028
Pathobiology of Liver Injury
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.9M · Mayo Clinic Rochester
2016–2027
Liquid Biopsy for Alcoholic Hepatitis: Diagnosis, Prognosis and Technology Development
National Institute on Alcohol Abuse and Alcoholism · U01
PI · $1.2M · Mayo Clinic Rochester
2012–2024
Organelle Dysfunction in Liver Inflammation
National Institute of Diabetes and Digestive and Kidney Diseases · R03
Contact PI · $159K · Mayo Clinic Rochester
2016–2017

Clinical trials

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
Site PI · Recruiting · Phase 3
Takeda
2024–2028
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Site PI · Recruiting · Phase 3
Takeda
2023–2031